A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug
Clinical Toxicology March 1, 2013 S. Rose, Justin L. Poklis, Alphonse Poklis
Context. Abuse of synthetic stimulant compounds resulting in significant toxicity is being increasingly reported by poison centers. Toxicologic assessment is complicated by inconsistent manufacturing processes and limited laboratory testing. We describe a case of self-reported exposure to 25-I (25I-NBOMe), a novel phenethylamine derivative, with subsequent quantification in serum. Case details....